Platelet Modulation of Polymorphonuclear Leukocyte Shear Induced Aggregation
Overview
Authors
Affiliations
A cone and plate viscometer and Coulter Counter were used to study platelet modulation of polymorphonuclear leukocyte (PMNL) aggregation caused by controlled shear stress. As an index of aggregation, the large-particle percentage (LPP) was calculated. This represents the ratio of aggregated cell count to total cell count. PMNL suspensions in buffer (1.0 X 10(7) cells per milliliter, final concentration) did not show any aggregate formation at shear stresses below 150 dynes/cm2 for one minute exposure time (LPP less than 3%). However, there was PMNL aggregation in mixed PMNL and platelet-rich plasma suspensions in this shear stress range. Supernatant plasma from sheared platelets initiated PMNL aggregation at moderate shear stress (150 dynes/cm2 for one minute; LPP, 20.3% +/- 2.5%). In contrast, platelet release factors, such as adenosine diphosphate (2 mumol/L) and serotonin (2 mumol/L) did not cause PMNL aggregation (LPP, 2.9% +/- 1.2% and 3.3% +/- 0.8%, respectively). The use of a cyclo-oxygenase inhibitor (acetylsalicylic acid, 50 mumol/L) did not suppress the aggregation of PMNLs after shear (LPP, 20.1% +/- 2.4%). However, preincubation with nordihydroguaiaretic acid (10 mumol/L), an inhibitor of C-5 and C-12 lipoxygenase, and 6,9-deepoxy-6,9-(phenylimino)-6,8-prostaglandin I1 (U-60257, 10 mumol/L), an inhibitor of C-5 lipoxygenase in human leukocytes, suppressed this aggregation (LPP, 9.1% +/- 2.5% and 10.4% +/- 3.2%, respectively). Also, the formation of lipoxygenase products (5-HETE, 12-HETE, 15-HETE, and LTB4) activated by shear stress was documented by reversed phase-high-performance liquid chromatography (RP-HPLC). These data support the possibility of a cooperation between platelets and leukocytes in shear-induced PMNL aggregation that is dependent on C-12 or C-5 lipoxygenase activity, or both.
12-lipoxygenase: a potential target for novel anti-platelet therapeutics.
Yeung J, Holinstat M Cardiovasc Hematol Agents Med Chem. 2011; 9(3):154-64.
PMID: 21838667 PMC: 3171607. DOI: 10.2174/187152511797037619.
Platelet lymphocyte adherence in children after surgery.
Aydar S, Yesilcimen K, Numanoglu S, Sonmezdag A Br J Exp Pathol. 1987; 68(4):595-9.
PMID: 3651326 PMC: 2013149.
Inhibition of human platelet activation by polymorphonuclear leukocytes.
Schattner M, Geffner J, Isturiz M, Lazzari M Br J Pharmacol. 1990; 101(2):253-6.
PMID: 2257433 PMC: 1917677. DOI: 10.1111/j.1476-5381.1990.tb12696.x.